Multivariate Optimization and Validation of a CZE Method for the Analysis of Pridinol Mesylate and Meloxicam in Tablets
- 14 July 2011
- journal article
- research article
- Published by Springer Nature in Chromatographia
- Vol. 74 (7-8) , 609-617
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- EXPERIMENTALLY DESIGNED, VALIDATED HPLC SIMULTANEOUS DETERMINATION OF PRIDINOL AND DICLOFENAC IN THEIR COMBINED PHARMACEUTICAL FORMULATIONS, WHICH ALLOWS LIMITING DICLOFENAC RELATED COMPOUND AJournal of Liquid Chromatography & Related Technologies, 2010
- Simultaneous determination of nine pyrethroids in indoor insecticide products by capillary gas chromatographyJournal of Pharmaceutical and Biomedical Analysis, 2010
- Development and validation of an HPLC method for the determination of process-related impurities in pridinol mesylate, employing experimental designsAnalytica Chimica Acta, 2009
- Validated stability-indicating HPLC method for the determination of pridinol mesylate. Kinetics study of its degradation in acid mediumJournal of Pharmaceutical and Biomedical Analysis, 2008
- Method development and validation for the simultaneous determination of meloxicam and pridinol mesylate using RP-HPLC and its application in drug formulationsJournal of Pharmaceutical and Biomedical Analysis, 2008
- Drug‐human serum albumin binding studied by capillary electrophoresis with electrochemiluminescence detectionElectrophoresis, 2004
- Method development and validation for the analysis of meloxicam in tablets by CZEJournal of Pharmaceutical and Biomedical Analysis, 2003
- MeloxicamDrugs, 1996
- The Histamine H1-Receptor Antagonist Binding Site. A Stereoselective Pharmacophoric Model Based upon (Semi-)Rigid H1-Antagonists and Including a Known Interaction Site on the ReceptorJournal of Medicinal Chemistry, 1995
- International guide to drugs for Parkinson's diseaseMovement Disorders, 1995